placebo group&gt

2 trials

Sponsors

The University of Tokyo Hospital Unit for Early and Exploratory Clinical Development, Department of Neurology, The University of Tokyo Hospital

Conditions

Healthy Elderly AdultMultiple system atrophy

Phase 1

A Randomized, Double-Blind, Placebo-Controlled, Sequential, Ascending Single and Multiple Dose, Safety, Tolerability, and Pharmacokinetic Study of TAK-070 in Healthy Elderly Subjects

Active, not recruitingJPRN-UMIN000010218

The University of Tokyo Hospital Unit for Early and Exploratory Clinical DevelopmentHealthy Elderly Adult

Start: 2013-03-11Target: 96Updated: 2026-06-29

A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose, Safety and Pharmacokinetic Study of MSA-01 (reduced form of CoQ10) in Healthy Adult Males

Active, not recruitingJPRN-UMIN000016695

Department of Neurology, The University of Tokyo HospitalMultiple system atrophy

Start: 2015-07-27Target: 24Updated: 2026-06-29

Related Papers

High-dose ubiquinol supplementation in multiple-system atrophy: a multicentre, randomised, double-blinded, placebo-controlled phase 2 trial.

2023-04-1419 citations

Randomized, double‐blind, placebo‐controlled phase 1 study to evaluate the safety and pharmacokinetics of high doses of ubiquinol in healthy adults

Neurology and Clinical Neuroscience2021-12-036 citations